blindness and glp 1 GLP-1 Drugs: An Ophthalmologist Explains NAION and GLP1s: Rare Cause
Description
Public awareness: Support campaigns that highlight disparities and promote inclusive solutions
Forty-four percent of firms with 1,000 to 4,999 workers, and 59% of firms with 5,000 or more workers, say that the use of these medications for weight loss was higher than expected
JAMA Neurology
Start by explaining your weight loss challenges and why you believe GLP-1 medication could be a good option
What forms of medication does Shed offer
adults seen as cost-secure fell from 61% in 2022 to 55% in 2023-24
